HIGH GRADE GLIOMA (III OR IV)
Clinical trials for HIGH GRADE GLIOMA (III OR IV) explained in plain language.
Never miss a new study
Get alerted when new HIGH GRADE GLIOMA (III OR IV) trials appear
Sign up with your email to follow new studies for HIGH GRADE GLIOMA (III OR IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug beat steroids for brain radiation injury?
Disease control Recruiting nowThis study compares bevacizumab, a drug that blocks blood vessel growth, to standard steroid treatment for people with brain damage from radiation therapy. About 408 adults with brain tumors or high-grade glioma who develop symptomatic radiation necrosis will be randomly assigned…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Glowing drug lights up brain tumors during surgery
Knowledge-focused Recruiting nowThis study tests a special version of the cancer drug nivolumab that has a fluorescent dye attached, called nivo800. The dye makes the drug glow under a special camera, allowing surgeons to see where the drug goes in the brain during tumor removal. The goal is to learn how well t…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Phase: EARLY_PHASE1 • Sponsor: Eben Rosenthal • Aim: Knowledge-focused
Last updated May 26, 2026 07:58 UTC
-
New smart needle aims to make brain tumor biopsies safer and more accurate
Knowledge-focused Recruiting nowThis study is developing a special biopsy needle that uses light and sound to help doctors see tumor tissue and blood vessels in real time. The goal is to make brain tumor biopsies safer and more accurate. The study will test the needle on tumor tissue removed during surgery from…
Matched conditions: HIGH GRADE GLIOMA (III OR IV)
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC